A citation-based method for searching scientific literature

Christine M Ribic, Daniel J Sargent, Malcolm J Moore, Stephen N Thibodeau, Amy J French, Richard M Goldberg, Stanley R Hamilton, Pierre Laurent-Puig, Robert Gryfe, Lois E Shepherd, Dongsheng Tu, Mark Redston, Steven Gallinger. N Engl J Med 2003
Times Cited: 1470







List of co-cited articles
645 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Defective mismatch repair as a predictive marker for lack of efficacy of fluorouracil-based adjuvant therapy in colon cancer.
Daniel J Sargent, Silvia Marsoni, Genevieve Monges, Stephen N Thibodeau, Roberto Labianca, Stanley R Hamilton, Amy J French, Brian Kabat, Nathan R Foster, Valter Torri,[...]. J Clin Oncol 2010
901
48

PD-1 Blockade in Tumors with Mismatch-Repair Deficiency.
Dung T Le, Jennifer N Uram, Hao Wang, Bjarne R Bartlett, Holly Kemberling, Aleksandra D Eyring, Andrew D Skora, Brandon S Luber, Nilofer S Azad, Dan Laheru,[...]. N Engl J Med 2015
32


The consensus molecular subtypes of colorectal cancer.
Justin Guinney, Rodrigo Dienstmann, Xin Wang, Aurélien de Reyniès, Andreas Schlicker, Charlotte Soneson, Laetitia Marisa, Paul Roepman, Gift Nyamundanda, Paolo Angelino,[...]. Nat Med 2015
21

Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade.
Dung T Le, Jennifer N Durham, Kellie N Smith, Hao Wang, Bjarne R Bartlett, Laveet K Aulakh, Steve Lu, Holly Kemberling, Cara Wilt, Brandon S Luber,[...]. Science 2017
21

Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study.
Michael J Overman, Ray McDermott, Joseph L Leach, Sara Lonardi, Heinz-Josef Lenz, Michael A Morse, Jayesh Desai, Andrew Hill, Michael Axelson, Rebecca A Moss,[...]. Lancet Oncol 2017
21

Durable Clinical Benefit With Nivolumab Plus Ipilimumab in DNA Mismatch Repair-Deficient/Microsatellite Instability-High Metastatic Colorectal Cancer.
Michael J Overman, Sara Lonardi, Ka Yeung Mark Wong, Heinz-Josef Lenz, Fabio Gelsomino, Massimo Aglietta, Michael A Morse, Eric Van Cutsem, Ray McDermott, Andrew Hill,[...]. J Clin Oncol 2018
751
20


A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer.
C R Boland, S N Thibodeau, S R Hamilton, D Sidransky, J R Eshleman, R W Burt, S J Meltzer, M A Rodriguez-Bigas, R Fodde, G N Ranzani,[...]. Cancer Res 1998
16

Microsatellite instability in colorectal cancer.
C Richard Boland, Ajay Goel. Gastroenterology 2010
16

Mismatch repair status and BRAF mutation status in metastatic colorectal cancer patients: a pooled analysis of the CAIRO, CAIRO2, COIN, and FOCUS studies.
Sabine Venderbosch, Iris D Nagtegaal, Tim S Maughan, Christopher G Smith, Jeremy P Cheadle, David Fisher, Richard Kaplan, Philip Quirke, Matthew T Seymour, Susan D Richman,[...]. Clin Cancer Res 2014
329
16

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
Freddie Bray, Jacques Ferlay, Isabelle Soerjomataram, Rebecca L Siegel, Lindsey A Torre, Ahmedin Jemal. CA Cancer J Clin 2018
16

Value of mismatch repair, KRAS, and BRAF mutations in predicting recurrence and benefits from chemotherapy in colorectal cancer.
Gordon Hutchins, Katie Southward, Kelly Handley, Laura Magill, Claire Beaumont, Jens Stahlschmidt, Susan Richman, Philip Chambers, Matthew Seymour, David Kerr,[...]. J Clin Oncol 2011
428
14

Microsatellite instability in cancer of the proximal colon.
S N Thibodeau, G Bren, D Schaid. Science 1993
13

Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability.
Asad Umar, C Richard Boland, Jonathan P Terdiman, Sapna Syngal, Albert de la Chapelle, Josef Rüschoff, Richard Fishel, Noralane M Lindor, Lawrence J Burgart, Richard Hamelin,[...]. J Natl Cancer Inst 2004
12


DNA mismatch repair status and colon cancer recurrence and survival in clinical trials of 5-fluorouracil-based adjuvant therapy.
Frank A Sinicrope, Nathan R Foster, Stephen N Thibodeau, Silvia Marsoni, Genevieve Monges, Roberto Labianca, George P Kim, Greg Yothers, Carmen Allegra, Malcolm J Moore,[...]. J Natl Cancer Inst 2011
332
11

Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer).
Heather Hampel, Wendy L Frankel, Edward Martin, Mark Arnold, Karamjit Khanduja, Philip Kuebler, Hidewaki Nakagawa, Kaisa Sotamaa, Thomas W Prior, Judith Westman,[...]. N Engl J Med 2005
923
11

Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer.
Thierry André, Corrado Boni, Lamia Mounedji-Boudiaf, Matilde Navarro, Josep Tabernero, Tamas Hickish, Clare Topham, Marta Zaninelli, Philip Clingan, John Bridgewater,[...]. N Engl J Med 2004
11

Tumor microsatellite instability and clinical outcome in young patients with colorectal cancer.
R Gryfe, H Kim, E T Hsieh, M D Aronson, E J Holowaty, S B Bull, M Redston, S Gallinger. N Engl J Med 2000
983
11

Use of 5-fluorouracil and survival in patients with microsatellite-unstable colorectal cancer.
John M Carethers, E Julieta Smith, Cynthia A Behling, Lanchinh Nguyen, Akihiro Tajima, Ryan T Doctolero, Betty L Cabrera, Ajay Goel, Christian A Arnold, Katsumi Miyai,[...]. Gastroenterology 2004
335
10

Microsatellite instability as a marker of prognosis and response to therapy: a meta-analysis of colorectal cancer survival data.
Cecilia Guastadisegni, Mauro Colafranceschi, Laura Ottini, Eugenia Dogliotti. Eur J Cancer 2010
253
10

Deficient mismatch repair system in patients with sporadic advanced colorectal cancer.
M Koopman, G A M Kortman, L Mekenkamp, M J L Ligtenberg, N Hoogerbrugge, N F Antonini, C J A Punt, J H J M van Krieken. Br J Cancer 2009
247
10

Microsatellite instability in colorectal cancer-the stable evidence.
Eduardo Vilar, Stephen B Gruber. Nat Rev Clin Oncol 2010
440
10

Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial.
Thierry André, Corrado Boni, Matilde Navarro, Josep Tabernero, Tamas Hickish, Clare Topham, Andrea Bonetti, Philip Clingan, John Bridgewater, Fernando Rivera,[...]. J Clin Oncol 2009
9

Mutation profiling and microsatellite instability in stage II and III colon cancer: an assessment of their prognostic and oxaliplatin predictive value.
Patrick G Gavin, Linda H Colangelo, Debora Fumagalli, Noriko Tanaka, Matthew Y Remillard, Greg Yothers, Chungyeul Kim, Yusuke Taniyama, Seung Il Kim, Hyun Joo Choi,[...]. Clin Cancer Res 2012
207
9

Neoadjuvant immunotherapy leads to pathological responses in MMR-proficient and MMR-deficient early-stage colon cancers.
Myriam Chalabi, Lorenzo F Fanchi, Krijn K Dijkstra, José G Van den Berg, Arend G Aalbers, Karolina Sikorska, Marta Lopez-Yurda, Cecile Grootscholten, Geerard L Beets, Petur Snaebjornsson,[...]. Nat Med 2020
185
9

Phase II Open-Label Study of Pembrolizumab in Treatment-Refractory, Microsatellite Instability-High/Mismatch Repair-Deficient Metastatic Colorectal Cancer: KEYNOTE-164.
Dung T Le, Tae Won Kim, Eric Van Cutsem, Ravit Geva, Dirk Jäger, Hiroki Hara, Matthew Burge, Bert O'Neil, Petr Kavan, Takayuki Yoshino,[...]. J Clin Oncol 2020
211
9

Pembrolizumab in Microsatellite-Instability-High Advanced Colorectal Cancer.
Thierry André, Kai-Keen Shiu, Tae Won Kim, Benny Vittrup Jensen, Lars Henrik Jensen, Cornelis Punt, Denis Smith, Rocio Garcia-Carbonero, Manuel Benavides, Peter Gibbs,[...]. N Engl J Med 2020
265
9

A genetic model for colorectal tumorigenesis.
E R Fearon, B Vogelstein. Cell 1990
8

Efficacy of Adjuvant Chemotherapy in Colon Cancer With Microsatellite Instability: A Large Multicenter AGEO Study.
David Tougeron, Guillaume Mouillet, Isabelle Trouilloud, Thierry Lecomte, Romain Coriat, Thomas Aparicio, Gaetan Des Guetz, Cédric Lécaille, Pascal Artru, Gaelle Sickersen,[...]. J Natl Cancer Inst 2016
80
10

Oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage II and III colon cancer: results from NSABP C-07.
J Philip Kuebler, H Samuel Wieand, Michael J O'Connell, Roy E Smith, Linda H Colangelo, Greg Yothers, Nicholas J Petrelli, Michael P Findlay, Thomas E Seay, James N Atkins,[...]. J Clin Oncol 2007
688
8

Adjuvant Fluorouracil, Leucovorin, and Oxaliplatin in Stage II to III Colon Cancer: Updated 10-Year Survival and Outcomes According to BRAF Mutation and Mismatch Repair Status of the MOSAIC Study.
Thierry André, Armand de Gramont, Dewi Vernerey, Benoist Chibaudel, Franck Bonnetain, Annemilaï Tijeras-Raballand, Aurelie Scriva, Tamas Hickish, Josep Tabernero, Jean Luc Van Laethem,[...]. J Clin Oncol 2015
303
8

Microsatellite instability and loss of heterozygosity at chromosomal location 18q: prospective evaluation of biomarkers for stages II and III colon cancer--a study of CALGB 9581 and 89803.
Monica M Bertagnolli, Mark Redston, Carolyn C Compton, Donna Niedzwiecki, Robert J Mayer, Richard M Goldberg, Thomas A Colacchio, Leonard B Saltz, Robert S Warren. J Clin Oncol 2011
112
8

Prognostic and predictive roles of high-degree microsatellite instability in colon cancer: a National Cancer Institute-National Surgical Adjuvant Breast and Bowel Project Collaborative Study.
George P Kim, Linda H Colangelo, H Samuel Wieand, Soonmyung Paik, Ilan R Kirsch, Norman Wolmark, Carmen J Allegra. J Clin Oncol 2007
243
8

Prognostic impact of deficient DNA mismatch repair in patients with stage III colon cancer from a randomized trial of FOLFOX-based adjuvant chemotherapy.
Frank A Sinicrope, Michelle R Mahoney, Thomas C Smyrk, Stephen N Thibodeau, Robert S Warren, Monica M Bertagnolli, Garth D Nelson, Richard M Goldberg, Daniel J Sargent, Steven R Alberts. J Clin Oncol 2013
170
8

The vigorous immune microenvironment of microsatellite instable colon cancer is balanced by multiple counter-inhibitory checkpoints.
Nicolas J Llosa, Michael Cruise, Ada Tam, Elizabeth C Wicks, Elizabeth M Hechenbleikner, Janis M Taube, Richard L Blosser, Hongni Fan, Hao Wang, Brandon S Luber,[...]. Cancer Discov 2015
779
8

First FDA Approval Agnostic of Cancer Site - When a Biomarker Defines the Indication.
Steven Lemery, Patricia Keegan, Richard Pazdur. N Engl J Med 2017
282
8

Reliable Pan-Cancer Microsatellite Instability Assessment by Using Targeted Next-Generation Sequencing Data.
Sumit Middha, Liying Zhang, Khedoudja Nafa, Gowtham Jayakumaran, Donna Wong, Hyunjae R Kim, Justyna Sadowska, Michael F Berger, Deborah F Delair, Jinru Shia,[...]. JCO Precis Oncol 2017
141
8


Colorectal cancer statistics, 2020.
Rebecca L Siegel, Kimberly D Miller, Ann Goding Sauer, Stacey A Fedewa, Lynn F Butterly, Joseph C Anderson, Andrea Cercek, Robert A Smith, Ahmedin Jemal. CA Cancer J Clin 2020
8

Prognostic Value of BRAF and KRAS Mutations in MSI and MSS Stage III Colon Cancer.
Julien Taieb, Karine Le Malicot, Qian Shi, Frédérique Penault-Llorca, Olivier Bouché, Josep Tabernero, Enrico Mini, Richard M Goldberg, Gunnar Folprecht, Jean Luc Van Laethem,[...]. J Natl Cancer Inst 2016
127
7

Systematic review of the predictive effect of MSI status in colorectal cancer patients undergoing 5FU-based chemotherapy.
Elizabeth M Webber, Tia L Kauffman, Elizabeth O'Connor, Katrina A B Goddard. BMC Cancer 2015
68
10

Microsatellite instability is a favorable prognostic indicator in patients with colorectal cancer receiving chemotherapy.
A Hemminki, J P Mecklin, H Järvinen, L A Aaltonen, H Joensuu. Gastroenterology 2000
285
7

Microsatellite instability and the clinicopathological features of sporadic colorectal cancer.
R Ward, A Meagher, I Tomlinson, T O'Connor, M Norrie, R Wu, N Hawkins. Gut 2001
277
7

Duration of Adjuvant Chemotherapy for Stage III Colon Cancer.
Axel Grothey, Alberto F Sobrero, Anthony F Shields, Takayuki Yoshino, James Paul, Julien Taieb, John Souglakos, Qian Shi, Rachel Kerr, Roberto Labianca,[...]. N Engl J Med 2018
362
7

Reduced likelihood of metastases in patients with microsatellite-unstable colorectal cancer.
Alberto Malesci, Luigi Laghi, Paolo Bianchi, Gabriele Delconte, Ann Randolph, Valter Torri, Carlo Carnaghi, Roberto Doci, Riccardo Rosati, Marco Montorsi,[...]. Clin Cancer Res 2007
174
7

Microsatellite instability testing and its role in the management of colorectal cancer.
Hisato Kawakami, Aziz Zaanan, Frank A Sinicrope. Curr Treat Options Oncol 2015
186
7

International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study.
Franck Pagès, Bernhard Mlecnik, Florence Marliot, Gabriela Bindea, Fang-Shu Ou, Carlo Bifulco, Alessandro Lugli, Inti Zlobec, Tilman T Rau, Martin D Berger,[...]. Lancet 2018
778
7

Microsatellite instability detection by next generation sequencing.
Stephen J Salipante, Sheena M Scroggins, Heather L Hampel, Emily H Turner, Colin C Pritchard. Clin Chem 2014
199
7


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.